Liver & Biliary Tree Enzymes: ALT, AST, ALP Flowchart

Added:

Limitations of Static Enzyme Flowcharts and the Shift to Multi-Marker Algorithms

While systematic flowcharts using ALT, AST, and ALP are fundamental clinical tools, critics argue they oversimplify liver pathology and often delay diagnosis. A major limitation is that standard liver enzyme levels can remain within "normal" ranges even in cases of advanced chronic liver disease, such as non-alcoholic fatty liver disease (NAFLD) or compensated cirrhosis. Furthermore, ALT and AST are not entirely liver-specific, and their levels fluctuate dynamically, leading to potential misinterpretation in isolated readings. To address these shortcomings, modern hepatology is shifting away from rigid, single-enzyme flowcharts toward integrated multi-marker algorithms and non-invasive fibrosis biomarkers (such as the FIB-4 index, ELF test, and transient elastography). These advanced approaches combine demographic data, metabolic risk factors, and specialized serum markers to assess liver health more dynamically. Critics advocate for redefining "normal" reference intervals for aminotransferases to improve sensitivity and integrating these holistic, algorithm-based risk-stratification models earlier in clinical pathways.

Basic anatomy of the liver, gallbladder, and biliary tree, including the flow of bile.
The metabolic pathway of bilirubin, including the difference between conjugated (direct) and unconjugated (indirect) bilirubin.
The concept of cellular enzymes (ALT, AST) and how their release into the bloodstream indicates hepatocyte injury.
Basic pathophysiology concepts of cellular inflammation (hepatitis) and physical blockages (biliary obstruction).
In-depth analysis of liver function test (LFT) ratios, such as the AST/ALT ratio (De Ritis ratio) to differentiate alcoholic hepatitis from other liver diseases.
Clinical diagnostic imaging modalities (such as abdominal ultrasound, CT, and MRCP) used to confirm biliary obstructions or fatty liver disease suspected from enzyme panels.
Pharmacological and surgical management of hepatocellular and cholestatic disorders, such as ERCP for gallstones or antiviral therapy for viral hepatitis.
The progression of acute liver injury to chronic states, including the pathophysiology of liver fibrosis, cirrhosis, and portal hypertension.
3.1K views78likes8:46@ASAPUSMLEOriginal Release: 2021-05-09

This video presents a systematic flow chart for diagnosing causes of elevated liver enzymes: ALT elevation indicates liver damage (NAFLD if obese/diabetic, alcoholic hepatitis if AST:ALT ratio 2:1 with normal albumin, or cirrhosis if low albumin); ALP elevation suggests biliary tree issues (gallstones if painful jaundice, cancer/stricture if painless, or autoimmune causes like PBC/PSC if GGT also elevated); and bilirubin elevation differentiates between unconjugated (Gilbert's syndrome if mild/stress-related, or severe conditions like Crigler-Najjar) and conjugated (Rotor or Dubin-Johnson syndromes based on urine urobilinogen).